Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London
· Delayed Price · Currency is GBP · Price in USD 559.00
+3.42 (0.61%)
At close: Aug 13, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 42.91 billion as of August 14, 2025. Its market cap has decreased by -52.54% in one year.
Market Cap
42.91B
Enterprise Value
31.99B
Revenue
10.37B
Ranking
n/a
PE Ratio
13.19
Stock Price
559.00
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 96.12M to 42.91B, an increase of 44,541.42%. That is a compound annual growth rate of 20.25%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.91B |
| GSK plc | 56.34B |
| Haleon | 31.86B |
| Smith & Nephew | 11.76B |
| ConvaTec Group | 4.64B |
| Hikma Pharmaceuticals | 3.95B |
| Oxford Nanopore Technologies | 2.04B |
| HUTCHMED (China) | 1.92B |